Sign in to continue:

Friday, July 31st, 2026

Day: June 8, 2026

Neurogene Completes Dosing in Pivotal Embolden™ Trial of NGN-401 Gene Therapy for Rett Syndrome

Neurogene Inc. Announces Completion of Dosing in Registratio...

Strive, Inc. Files 8-K Reporting Merger Transaction and SATA Stock Information – June 2026

Strive, Inc. (NASDAQ: ASST, SATA) Announces Bitcoin Purchase...